Cargando…
Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms
Coronary heart disease (CHD) remains a major cause of mortality with a huge economic burden on healthcare worldwide. Here, we conducted a systematic review to investigate the efficacy and safety of Chinese herbal medicine (CHM) for CHD based on high-quality randomized controlled trials (RCTs) and su...
Autores principales: | Zhang, Ke-Jian, Zheng, Qun, Zhu, Peng-Chong, Tong, Qiang, Zhuang, Zhuang, Zhu, Jia-Zhen, Bao, Xiao-Yi, Huang, Yue-Yue, Zheng, Guo-Qing, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688122/ https://www.ncbi.nlm.nih.gov/pubmed/31427964 http://dx.doi.org/10.3389/fphar.2019.00844 |
Ejemplares similares
-
Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
por: Zheng, Qun, et al.
Publicado: (2018) -
Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool
por: Bao, Xiao-yi, et al.
Publicado: (2018) -
Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism
por: Zhang, Ke-Jian, et al.
Publicado: (2017) -
Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022) -
Traditional Chinese Medicine is an Alternative Therapeutic Option for Treatment of Pseudomonas aeruginosa Infections
por: Pang, Zheng, et al.
Publicado: (2021)